Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation (original) (raw)
References
Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphee AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779–784 ArticleCASPubMed Google Scholar
Choyke PL, Glenn GW, Patronas NJ, Linehan WM, Zbar B (1995) Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194: 629–642 CASPubMed Google Scholar
Crossey PA, Foster K, Richards FM, Phipps ME, Latif F, Tory K, Jones MH, Bentley E, Kumar R, Lerman MI et al (1994a) Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 93: 53–58 ArticleCASPubMed Google Scholar
Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman M, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER (1994b) Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 3: 1303–1308 CASPubMed Google Scholar
Davies DR, Norman AM, Whitehouse RW, Evans DG (1994) Non-expression of von Hippel-Lindau phenotype in an obligate gene carrier. Clin Genet 45: 104–106 CASPubMed Google Scholar
Decker HJ, Neumann HP, Walter TA, Sandberg AA (1988) 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p. Cancer Genet Cytogenet 33: 59–65 ArticleCASPubMed Google Scholar
Decker HJ, Gemmill RM, Neumann HP, Walter TA, Sandberg AA (1989) Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome. Cancer Genet Cytogenet 39: 289–293 ArticleCASPubMed Google Scholar
Decker HJ, Cannizzaro LA, Mendez MJ, Leong SP, Bixenman H, Berger C, Sandberg AA (1990) Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study. Hum Genet 85: 337–342 ArticleCASPubMed Google Scholar
Decker HJ, Klauck SM, Lawrence JB, McNeil J, Smith D, Gemmill RM, Sandberg AA, Neumann HH, Simon B, Green J, et al (1994) Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von HippelLindau syndrome (VHL). Cancer Genet Cytogenet 77: 1- 13 ArticleCASPubMed Google Scholar
Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER (1994a) Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 1lp, 17 and 22. Br J Cancer 69: 230–234 CASPubMed Google Scholar
Foster K, Prowse A, Berg A van den, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM, Maher ER (1994b) Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3: 2169–2173 CASPubMed Google Scholar
Glenn GM, Daniel LN, Choyke P, Linehan WM, Oldfield E, Gorin MB, Hosoe S, Latif F, Weiss G, Walther M et al (1991) Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet 87: 207–210 ArticleCASPubMed Google Scholar
Glenn GM, Linehan WM, Hosoe S, Latif F, Yao M, Choyke P, Gorin MB, Chew E, Olfield E, Manolatos C et al (1992) Screening for von Hippel-Lindau disease by DNA polymorphism analysis. J Am Med Assoc 267: 1226–1231 ArticleCAS Google Scholar
Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7: 85–89 ArticleCASPubMed Google Scholar
Horton WA, Wong V, Eldrigde R (1976) Von Hippel-Lindau disease. Clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 136: 769–777 ArticleCASPubMed Google Scholar
Hosoe S, Brauch H, Latif F, Glenn G, Daniel L, Bale S, Choyke P, Gorin M, Oldfield E, Berman A et al (1990) Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8: 634–640 ArticleCASPubMed Google Scholar
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818–821 CASPubMed Google Scholar
Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M (1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54: 4845–4847 CASPubMed Google Scholar
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823 PubMed Google Scholar
Kovacs G, Kung HF (1991) Nonhomologous chromatid exchange in hereditary and sporadic renal cell carinomas. Proc Natl Acad Sci USA 88: 194–198 CASPubMed Google Scholar
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene [see comments]. Science 260: 1317–1320 CASPubMed Google Scholar
Lengauer C, Riethman HC, Speicher M, Taniwaki M, Konecki D, Green ED, Becher R, Olson M, Cremer T (1992) Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2. Cancer Res 52: 2590–2596 CASPubMed Google Scholar
Maher ER (1993) Von Hippel-Lindau disease. In: Hodgson SV, Maher ER (eds) A practical guide to human cancer genetics. Cambridge University Press, Cambridge, pp 157–162 Google Scholar
Maher ER, Bentley E, Yates JR, Latif F, Lerman M, Zbar B, Affara NA, Ferguson-Smith MA (1991a) Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. Genomics 10: 957–960 ArticleCASPubMed Google Scholar
Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N (1991b) Von Hippel-Lindau disease: a genetic study. J Med Genet 28: 443–447 CASPubMed Google Scholar
Manoir S du, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90: 590–610 ArticlePubMed Google Scholar
Melmon KL, Rosen SW (1964) Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36: 595–617 ArticleCASPubMed Google Scholar
Neumann HP (1987) Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. Vasa 16: 220–226 CASPubMed Google Scholar
Neumann HP, Lips CJM, Hsia YE, Zbar B (1995) Von Hippel-Lindau syndrome. Brain Pathol 5: 181–193 CASPubMed Google Scholar
Richards FM, Crossey PA, Phipps ME, Foster K, Latif F, Evans GA, Sampson J, Lerman M, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER (1994) Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet 3: 595–598 CASPubMed Google Scholar
Ried T, Lengauer C, Lipp M, Fischer C, Cremer T, Ward DC (1993) Evaluation of the utility of interphase cytogenetics to detect residual cells with a malignant genotype in mixed cell populations: a Burkitt lymphoma model. DNA Cell Biol 12: 637–643 CASPubMed Google Scholar
Ried T, Petersen I, Holtgreve Grez H, Speicher MR, Schrock E, Manoir S du, Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54: 1801–1806 CASPubMed Google Scholar
Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor Krakauer D et al (1988) Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269 ArticleCASPubMed Google Scholar
Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Klauck SM, Whaley J, Decker HJ et al (1991) Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel-Lindau disease. Proc Natl Acad Sci USA 88: 2864–2868 CASPubMed Google Scholar
Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI, Minna JD (1994) Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9: 1599–1604 CASPubMed Google Scholar
Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852–2855 CASPubMed Google Scholar
Steinbach F, Stöckle M, Müller SC, Thüroff JW, Melchior SW, Stein R, Hohenfellner R (1992) Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol 148: 24–29 CASPubMed Google Scholar
Tory K, Brauch H, Linehan M, Barba D, Oldfield E, Filling-Katz M, Seizinger B, Nakamura Y, White R, Marshall FF et al (1989) Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81: 1097–1101 CASPubMed Google Scholar
Vance JM, Small KW, Jones MA, Stajich JM, Yamaoka LH, Roses AD, Hung WY, Pericak Vance MA (1990) Confirmation of linkage in von Hippel-Lindau disease. Genomics 6: 565–567 ArticleCASPubMed Google Scholar
Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP et al (1994) Germline mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55: 1092–1102 CASPubMed Google Scholar